Hubei Hongyuan Pharmaceutical Technology Co's quarterly market cap
declined
from Sep. 2023 (¥11,260 Mil) to Dec. 2023 (¥10,392 Mil) and
declined
from Dec. 2023 (¥10,392 Mil) to Mar. 2024 (¥6,880 Mil).
Hubei Hongyuan Pharmaceutical Technology Co's annual market cap
stayed the same
from Dec. 2021 (¥0 Mil) to Dec. 2022 (¥0 Mil) but then
increased
from Dec. 2022 (¥0 Mil) to Dec. 2023 (¥10,392 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hubei Hongyuan Pharmaceutical Technology Co's Enterprise Value for Today is ¥4,805 Mil.
Hubei Hongyuan Pharmaceutical Technology Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Hubei Hongyuan Pharmaceutical Technology Co Market Cap Chart
Hubei Hongyuan Pharmaceutical Technology Co Annual Data
Competitive Comparison of Hubei Hongyuan Pharmaceutical Technology Co's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Hongyuan Pharmaceutical Technology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hubei Hongyuan Pharmaceutical Technology Co's Market Cap Distribution in the Drug Manufacturers Industry
* The bar in red indicates where Hubei Hongyuan Pharmaceutical Technology Co's Market Cap falls into.
Hubei Hongyuan Pharmaceutical Technology Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hubei Hongyuan Pharmaceutical Technology Co Market Cap Related Terms
Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.
Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:301246 has been successfully added to your 